News from the FDA/CDC
News from the FDA/CDC
Zika slowing, but not going away
New cases of pregnant women with Zika infection are down, but five more infants born with Zika-related birth defects have been reported.
News from the FDA/CDC
Brodalumab approved for psoriasis with REMS required
The FDA has approved brodalumab for treating moderate to severe psoriasis, with a REMS that addresses a risk of suicidal ideation and behavior...
News from the FDA/CDC
Flu activity levels high in 23 states
Main nationwide influenza activity measure reaches it highest point since the end of 2014.
News from the FDA/CDC
ACIP releases updated guidance for adult vaccinations
Effectiveness of certain flu vaccine formulations may be unacceptably low in certain populations.
News from the FDA/CDC
High levels of flu activity reported in 15 states
Fifteen states experienced high levels of flu activity for the week ending Jan. 28 as the 2016-2017 season moved past last season’s peak,...
News from the FDA/CDC
New Zika-infected pregnancies down for most of United States
New cases of Zika infection in pregnant women were down again for the 50 states over the 2-week reporting period ending Jan. 24, but U.S....
News from the FDA/CDC
Increase brings flu activity back to seasonal high
The level of influenza-like illness activity was highest in five states for the week ending Jan. 21, compared with three states the week before,...
News from the FDA/CDC
Second dose rates of meningococcal vaccines low among HIV-positive men who have sex with men
More active surveillance needs to be done by local health departments, study finds.
News from the FDA/CDC
West Nile virus accounted for 95% of domestic arboviral disease in 2015
The CDC reports that West Nile virus was the most common cause of domestically acquired arboviral disease in 2015.
News from the FDA/CDC
FDA approves Trulance for chronic idiopathic constipation
Trulance, a once-daily oral medication for chronic idiopathic constipation, has been approved by the Food and Drug Administration for adult...
News from the FDA/CDC
FDA approves topical oxymetazoline for rosacea
A topical cream containing the vasoconstrictor oxymetazoline has been approved by the Food and Drug Administration to treat symptoms of rosacea,...